Skip to content

Leukemic Stem Cell Subtypes Drive Distinct Niche Remodeling in Acute Myeloid Leukemia

Aug 2026 · bioRxiv · 0 citations · 29 references
Biology

TL;DR

Findings identify a specific LSC subtype as a source of niche-remodeling cues that shape specialized leukemia-supportive niches that shape specialized leukemia-supportive niches in vivo.

View source

Similar papers

Open access Aug 2026

Single-cell Atlas Reveals Myelopoietic Bias and Immunosuppressive Reprogramming in Metastatic Bone Marrow Across Cancers.

Bone metastasis can remodel the bone marrow microenvironment, yet how metastatic tumors reshape hematopoiesis and immunity across marrow regions remains poorly defined. Here, we profile a cross-cancer single-cell atlas with 126,986 cells by integrating bone marrow samples (tumor, involved, and distal sites) from liver,...

Zhi-Long Shen, Shao-Xuan Wang, Hao Jiang et al. · 0 citations
Open access Aug 2026

Bone marrow mesenchymal stem cells are functionally remodeled after complete remission of acute myeloid leukemia

Abstract Background and Objectives Acute myeloid leukemia (AML) is a type of hematological malignancy, induces the normal bone marrow (BM) microenvironment to supporting AML cells. Although previous work revealed that functional remodeling of BM endothelial progenitor cells after complete remission (CR), as another imp...

Zhi-wei Zhang, Zhenkun Wang, Xin-Yan Zhang et al. · 0 citations
Open access Oct 2026

Latexin deletion in the bone marrow niche suppresses leukemia via LIFR downregulation and immune activation.

Acute myeloid leukemia (AML) is the most common adult leukemia diagnosis. Bone marrow (BM) niche significantly influences the initiation and progression of AML. However, our knowledge about the effect of leukemic niche on leukemia stem cells (LSC) and leukemogenesis is limited. In this study, we identified an extrinsic...

Cui-Ping Zhang, Xia Yao, Pin-Pin Sui et al. · 0 citations
Oct 2026

Leukemia-associated myeloid cells support distinct T-ALL subtypes via unique signals converging on metabolic alterations.

Although intensified chemotherapy regimens have improved survival of T-cell acute lymphoblastic leukemia (T-ALL) patients, treatment-related toxicities and poor outcomes following relapse highlight the need for alternative therapeutics. Our previous studies showed that leukemia-associated myeloid cells support T-ALL pr...

S. Nam, Doris Narki Tetteh, Elizabeth M. Kappil et al. · 0 citations
Sep 2026

LPCAT3 is essential for leukemia progression and represents a therapeutic vulnerability in AML

RNA-seq following LPCAT3 loss showed that genes differentially expressed were significantly enriched in granulocyte chemotaxis–related pathways, suggesting a role of LPCAT3 in modulation of leukemic differentiation programs and microenvironmental interactions, established that LPCAT3 as a previously unrecognized mediat...

Mu-Tian Cao, L. Cong, Yi-Fei He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.